TET2 and cancer: Notably, high concentrations of vitamin C administration with or without anticancer drugs have not shown serious adverse effects in clinical trials, suggesting that vitamin C is a drug with low toxicity.263–267 Therefore, vitamin C might be a promising anticancer treatment option for cancer patients with dysfunctions of TET2 in the future.